Current Headlines

  1. BioOutsource Opens New Facility In Glasgow

    BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, recently announced the opening of a new facility which doubles Biooutsource’s capacity for future growth.

  2. 3SBio Acquires Zhejiang Wansheng Pharmaceutical

    3SBio Inc., (HKEX:1530) ("3SBio" or 'the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the entire equity interest in Zhejiang Wansheng Pharmaceutical Co., Ltd ("Zhejiang Wansheng") a limited liability company incorporated in the PRC for an aggregate consideration of RMB 528 million.

  3. Lysogene and Alcyone Lifesciences Enter a Collaboration for Mucopolysaccharidosis Type IIIA (MPS IIIA)

    Lysogene and Alcyone Lifesciences enter into a collaboration for mucopolysaccharidosis type IIIA (MPS IIIA). The collaboration combines the companies’ expertise in proprietary recombinant adeno-associated virus (rAAV) based gene therapy and MEMS based targeted drug delivery

  4. Grace Introduces DARACLAR 9000HP, New Beer Stabilizer That Increases Productivity, Reduces Environmental Impact

    W. R. Grace & Co. (NYSE: GRA) announces a breakthrough in beer stabilization that increases brewing productivity while decreasing the amount of water used and solid waste created in the brewing process.

  5. Clever FlexiBulk Tip Packs – Save Space and Effort in Your Lab

    Sartorius Stedim Biotech (SSB), a leading international laboratory and pharmaceutical supplier, introduces a completely new concept for packaging pipette tips: FlexiBulk. 

  6. IRESSA (gefitinib) Approved By The U.S. Food And Drug Administration For First-Line Treatment Of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

    AstraZeneca recently announced that the U.S. Food and Drug Administration (FDA) has approved IRESSA (gefitinib) as a first-line treatment in patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

  7. Save Time And Costs With The All-New PROPOR TFF Filter Range

    PROPOR TFF, Parker domnick hunter’s new range of hollow fibre tangential flow filters, offers a number of benefits for microfiltration and ultrafiltration applications in the biopharmaceutical industry.

  8. Sartorius Stedim Biotech Acquires Cellca

    Sartorius Stedim Biotech (SSB), a leading international supplier for the pharma and biotech industries, acquired Cellca GmbH based in Laupheim, Germany, last Wednesday.

  9. Fast Liquid Transfer Down To Picoliter Levels With Tecan’s D300e

    Tecan has introduced the D300e Digital Dispenser* for applications that need faster, reliable dispensing down to picoliter volumes.

  10. LINK Strengthens Presence In Japan With Cosmo Bio And Shigematsu Distribution Agreements

    LINK, the innovative developer and manufacturer of nucleic acid reagents, has announced the appointment of two new distributors in Japan - Cosmo Bio and Shigematsu. The companies will work alongside LINK’s current partner, Gene Design, thus strengthening LINK’s presence in this important market and increasing access to its range of innovative reagents for oligo therapeutics and diagnostics.

Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.